KXD1
gene geneOn this page
Also known as FLJ25480MGC2749KXDLBORCS4
Summary
KXD1 (KxDL motif containing 1, HGNC:28420) is a protein-coding gene on chromosome 19p13.11, encoding KxDL motif-containing protein 1 (Q9BQD3). As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery.
Involved in lysosome localization. Part of BORC complex.
Source: NCBI Gene 79036 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_024069
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28420 |
| Approved symbol | KXD1 |
| Name | KxDL motif containing 1 |
| Location | 19p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25480, MGC2749, KXDL, BORCS4 |
| Ensembl gene | ENSG00000105700 |
| Ensembl biotype | protein_coding |
| OMIM | 615178 |
| Entrez | 79036 |
Gene structure
Transcript identifiers
Ensembl transcripts: 55 — 53 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000222307, ENST00000539106, ENST00000540691, ENST00000595073, ENST00000595870, ENST00000596244, ENST00000596785, ENST00000597438, ENST00000598830, ENST00000599000, ENST00000599319, ENST00000600099, ENST00000600372, ENST00000600654, ENST00000600796, ENST00000601630, ENST00000602094, ENST00000859406, ENST00000859407, ENST00000859408, ENST00000859409, ENST00000859410, ENST00000859411, ENST00000859412, ENST00000859413, ENST00000859414, ENST00000859415, ENST00000859416, ENST00000859417, ENST00000859418, ENST00000859419, ENST00000859420, ENST00000859421, ENST00000859422, ENST00000859423, ENST00000916832, ENST00000916833, ENST00000916834, ENST00000916835, ENST00000916836, ENST00000916837, ENST00000916838, ENST00000916839, ENST00000916840, ENST00000916841, ENST00000916842, ENST00000916843, ENST00000916844, ENST00000970587, ENST00000970588, ENST00000970589, ENST00000970590, ENST00000970591, ENST00000970592, ENST00000970593
RefSeq mRNA: 3 — MANE Select: NM_024069
NM_001171948, NM_001171949, NM_024069
CCDS: CCDS12381
Canonical transcript exons
ENST00000222307 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000691175 | 18567132 | 18567178 |
| ENSE00000691177 | 18564869 | 18565021 |
| ENSE00000691179 | 18562036 | 18562157 |
| ENSE00003041479 | 18557870 | 18557914 |
| ENSE00003190256 | 18568402 | 18569378 |
Expression profiles
Bgee: expression breadth ubiquitous, 282 present calls, max score 97.32.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 135.2630 / max 1407.2220, expressed in 1828 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174685 | 70.4871 | 1827 |
| 174682 | 44.0566 | 1814 |
| 174684 | 12.1969 | 1806 |
| 174683 | 7.9062 | 1757 |
| 174686 | 0.6161 | 273 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right coronary artery | UBERON:0001625 | 97.32 | gold quality |
| popliteal artery | UBERON:0002250 | 97.27 | gold quality |
| tibial artery | UBERON:0007610 | 97.27 | gold quality |
| lower esophagus | UBERON:0013473 | 97.17 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.17 | gold quality |
| ascending aorta | UBERON:0001496 | 97.15 | gold quality |
| aorta | UBERON:0000947 | 97.14 | gold quality |
| thoracic aorta | UBERON:0001515 | 97.14 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 97.13 | gold quality |
| nerve | UBERON:0001021 | 97.09 | gold quality |
| tibial nerve | UBERON:0001323 | 97.09 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 97.04 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 96.96 | gold quality |
| left coronary artery | UBERON:0001626 | 96.95 | gold quality |
| granulocyte | CL:0000094 | 96.90 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.81 | gold quality |
| mucosa of stomach | UBERON:0001199 | 96.66 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.59 | gold quality |
| body of pancreas | UBERON:0001150 | 96.55 | gold quality |
| stromal cell of endometrium | CL:0002255 | 96.50 | gold quality |
| coronary artery | UBERON:0001621 | 96.48 | gold quality |
| monocyte | CL:0000576 | 96.44 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 96.40 | gold quality |
| right testis | UBERON:0004534 | 96.39 | gold quality |
| body of stomach | UBERON:0001161 | 96.36 | gold quality |
| left ovary | UBERON:0002119 | 96.33 | gold quality |
| left testis | UBERON:0004533 | 96.31 | gold quality |
| body of uterus | UBERON:0009853 | 96.25 | gold quality |
| endocervix | UBERON:0000458 | 96.24 | gold quality |
| mononuclear cell | CL:0000842 | 96.15 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6379 | no | 535.23 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
33 targeting KXD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-623 | 99.76 | 68.16 | 1170 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-3064-5P | 99.26 | 66.13 | 1497 |
| HSA-MIR-3085-3P | 99.26 | 66.16 | 1490 |
| HSA-MIR-6504-5P | 99.26 | 65.95 | 1487 |
| HSA-MIR-149-5P | 99.25 | 67.16 | 1315 |
| HSA-MIR-4711-3P | 98.97 | 66.87 | 1020 |
| HSA-MIR-4656 | 98.79 | 66.22 | 1306 |
| HSA-MIR-340-3P | 98.11 | 68.25 | 679 |
| HSA-MIR-6827-3P | 98.08 | 72.27 | 651 |
| HSA-MIR-3173-5P | 97.35 | 65.82 | 1282 |
| HSA-MIR-6799-3P | 97.35 | 65.60 | 1302 |
| HSA-MIR-6859-3P | 97.26 | 64.69 | 428 |
| HSA-MIR-505-5P | 97.01 | 65.54 | 778 |
Literature-anchored findings (GeneRIF, showing 2)
- KXD1 interacts with BLOS1. (PMID:22554196)
- BORC complex specific components and Kinesin-1 mediate autophagy evasion by the autophagy-resistant Mycobacterium tuberculosis Beijing strain. (PMID:36717601)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kxd1 | ENSDARG00000051934 |
| mus_musculus | Kxd1 | ENSMUSG00000055553 |
| rattus_norvegicus | Kxd1 | ENSRNOG00000019971 |
| drosophila_melanogaster | CG10681 | FBGN0036291 |
| caenorhabditis_elegans | WBGENE00015742 |
Protein
Protein identifiers
KxDL motif-containing protein 1 — Q9BQD3 (reviewed: Q9BQD3)
All UniProt accessions (8): Q9BQD3, M0QX74, M0QXN9, M0QXP3, M0QY77, M0R0B4, M0R228, M0R2G3
UniProt curated annotations — full annotation on UniProt →
Function. As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor. May be involved in the biogenesis of lysosome-related organelles such as melanosomes.
Subunit / interactions. Component of the BLOC-one-related complex (BORC) which is composed of BLOC1S1, BLOC1S2, BORCS5, BORCS6, BORCS7, BORCS8, KXD1 and SNAPIN. Associates with the BLOC-1 complex. Interacts with BLOC1S1. Interacts with DTNBP1/BLOC1S7 (via coiled-coil domain).
Subcellular location. Lysosome membrane.
Similarity. Belongs to the KXD1 family.
RefSeq proteins (3): NP_001165419, NP_001165420, NP_076974* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019371 | KxDL_dom | Domain |
| IPR039843 | KXD1-like | Family |
Pfam: PF10241
UniProt features (6 total): compositionally biased region 2, chain 1, region of interest 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BQD3-F1 | 77.02 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 1
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 192 (showing top):
MORF_DNMT1, GOCC_VACUOLAR_MEMBRANE, MORF_SNRP70, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, MORF_UBE2I, MORF_HDAC1, MORF_UBE2N, MORF_CDK2, MORF_HDAC2, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE, MORF_TERF1, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, MORF_SKP1A, MORF_RAF1
GO Biological Process (5): vesicle-mediated transport (GO:0016192), lysosome localization (GO:0032418), regulation of endosome size (GO:0051036), regulation of lysosome size (GO:0062196), organelle transport along microtubule (GO:0072384)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): cytoplasmic side of lysosomal membrane (GO:0098574), BORC complex (GO:0099078), lysosome (GO:0005764), lysosomal membrane (GO:0005765), membrane (GO:0016020), BLOC-1 complex (GO:0031083)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 1 |
| cellular process | 1 |
| vacuolar localization | 1 |
| regulation of vesicle size | 1 |
| regulation of cellular component size | 1 |
| transport along microtubule | 1 |
| establishment of organelle localization | 1 |
| binding | 1 |
| lysosomal membrane | 1 |
| cytoplasmic side of membrane | 1 |
| intracellular protein-containing complex | 1 |
| lytic vacuole | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
| cellular anatomical structure | 1 |
| BLOC complex | 1 |
Protein interactions and networks
STRING
707 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KXD1 | BORCS6 | Q96GS4 | 995 |
| KXD1 | BLOC1S1 | P78537 | 991 |
| KXD1 | BORCS5 | Q969J3 | 990 |
| KXD1 | BLOC1S2 | Q6QNY1 | 989 |
| KXD1 | SNAPIN | O95295 | 988 |
| KXD1 | BORCS7 | Q96B45 | 987 |
| KXD1 | BORCS8 | Q96FH0 | 985 |
| KXD1 | ARL8B | Q9NVJ2 | 677 |
| KXD1 | ARL8A | Q96BM9 | 634 |
| KXD1 | ARL5B | Q96KC2 | 606 |
| KXD1 | BLOC1S6 | Q9UL45 | 543 |
| KXD1 | DDX49 | Q9Y6V7 | 492 |
| KXD1 | AP3M1 | Q9Y2T2 | 475 |
| KXD1 | TMEM59L | Q9UK28 | 466 |
| KXD1 | PGPEP1 | Q9NXJ5 | 455 |
IntAct
201 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LAMTOR4 | LAMTOR5 | psi-mi:“MI:0914”(association) | 0.960 |
| KXD1 | TPM3 | psi-mi:“MI:0915”(physical association) | 0.920 |
| TPM3 | KXD1 | psi-mi:“MI:0915”(physical association) | 0.920 |
| BLOC1S1 | SNAPIN | psi-mi:“MI:0914”(association) | 0.810 |
| KXD1 | TPM1 | psi-mi:“MI:0915”(physical association) | 0.800 |
| TPM1 | KXD1 | psi-mi:“MI:0915”(physical association) | 0.800 |
| BORCS6 | KXD1 | psi-mi:“MI:0915”(physical association) | 0.800 |
| EXOC3 | EXOC5 | psi-mi:“MI:0914”(association) | 0.790 |
| KXD1 | CEP19 | psi-mi:“MI:0915”(physical association) | 0.780 |
| CEP19 | KXD1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| IFT20 | KXD1 | psi-mi:“MI:0915”(physical association) | 0.770 |
| KXD1 | IFT20 | psi-mi:“MI:0915”(physical association) | 0.770 |
| TPM1 | KXD1 | psi-mi:“MI:0915”(physical association) | 0.740 |
BioGRID (234): KXD1 (Two-hybrid), KXD1 (Two-hybrid), KXD1 (Two-hybrid), KXD1 (Two-hybrid), KXD1 (Two-hybrid), KXD1 (Two-hybrid), KXD1 (Two-hybrid), MAP1LC3B (Two-hybrid), MAP1LC3A (Two-hybrid), CEP19 (Two-hybrid), IFT20 (Two-hybrid), HAUS1 (Two-hybrid), ZNF417 (Two-hybrid), LRRC45 (Two-hybrid), C4orf46 (Two-hybrid)
ESM2 similar proteins: A0JPN6, A4IIZ9, A5WUL3, A8E5U3, F1R7R1, F4HPA7, F4HRV8, O43513, O57595, O75934, P61289, P61290, P61291, Q15528, Q2F7Z4, Q2TBN4, Q2YDF2, Q3B8I4, Q3T123, Q4R4V3, Q5BJ48, Q5E9K2, Q5F3J5, Q5PPY2, Q5RFD3, Q5RHQ8, Q5RKN3, Q5XIX8, Q5ZKF4, Q62276, Q62717, Q62739, Q68EF0, Q6GLR7, Q6GPR9, Q6GQ95, Q7ZV35, Q800L3, Q80TJ1, Q86UW7
Diamond homologs: A2XK00, Q0V9C8, Q3SZV2, Q5M853, Q6ASS9, Q6DBR9, Q6DDT0, Q80XH1, Q9BQD3, Q9VTY4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 104 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Autophagy | 6 | 14.3× | 5e-04 |
| Macroautophagy | 7 | 13.0× | 3e-04 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 5 | 12.4× | 3e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| lysosome localization | 7 | 42.9× | 1e-07 |
| exocytosis | 6 | 10.6× | 9e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1021 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:18562028:T:TA | acceptor_gain | 1.0000 |
| 19:18562031:TTCA:T | acceptor_loss | 1.0000 |
| 19:18562033:CA:C | acceptor_loss | 1.0000 |
| 19:18562034:A:AG | acceptor_gain | 1.0000 |
| 19:18562034:A:T | acceptor_loss | 1.0000 |
| 19:18562035:G:A | acceptor_loss | 1.0000 |
| 19:18562035:G:GT | acceptor_gain | 1.0000 |
| 19:18562035:GGC:G | acceptor_gain | 1.0000 |
| 19:18562035:GGCA:G | acceptor_gain | 1.0000 |
| 19:18562153:AACAT:A | donor_gain | 1.0000 |
| 19:18562154:ACAT:A | donor_gain | 1.0000 |
| 19:18562155:CAT:C | donor_gain | 1.0000 |
| 19:18562155:CATGT:C | donor_loss | 1.0000 |
| 19:18562156:AT:A | donor_gain | 1.0000 |
| 19:18562158:G:GG | donor_gain | 1.0000 |
| 19:18564861:A:AG | acceptor_gain | 1.0000 |
| 19:18564862:C:G | acceptor_gain | 1.0000 |
| 19:18564864:A:AG | acceptor_gain | 1.0000 |
| 19:18564864:ATCAG:A | acceptor_gain | 1.0000 |
| 19:18564865:TCA:T | acceptor_loss | 1.0000 |
| 19:18564866:CA:C | acceptor_loss | 1.0000 |
| 19:18564867:A:AC | acceptor_loss | 1.0000 |
| 19:18564867:A:AG | acceptor_gain | 1.0000 |
| 19:18564867:AG:A | acceptor_gain | 1.0000 |
| 19:18564867:AGGCT:A | acceptor_gain | 1.0000 |
| 19:18564868:G:GA | acceptor_gain | 1.0000 |
| 19:18564868:GG:G | acceptor_gain | 1.0000 |
| 19:18564868:GGC:G | acceptor_gain | 1.0000 |
| 19:18564868:GGCT:G | acceptor_gain | 1.0000 |
| 19:18564868:GGCTG:G | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000428222 (19:18559522 A>G), RS1000428428 (19:18563628 C>G), RS1000520443 (19:18567483 T>C), RS1000927359 (19:18556923 C>A,T), RS1000954637 (19:18567669 C>T), RS1001025787 (19:18562648 G>A), RS1001232945 (19:18557824 C>T), RS1001358517 (19:18557546 C>T), RS1001472505 (19:18566687 G>A), RS1001754503 (19:18568296 A>C,G), RS1001829954 (19:18556664 T>A,C), RS1002205600 (19:18562228 C>T), RS1002517553 (19:18559105 A>G), RS1002642520 (19:18556177 C>A,T), RS1003194322 (19:18567741 C>T)
Disease associations
OMIM: gene MIM:615178 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases oxidation, affects expression, affects cotreatment | 2 |
| Ozone | affects cotreatment, increases oxidation, increases abundance, affects expression | 2 |
| Valproic Acid | decreases expression, increases methylation | 2 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, increases oxidation, increases abundance | 1 |
| beta-lapachone | decreases expression | 1 |
| methacrylaldehyde | increases oxidation, increases abundance, affects cotreatment | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acrolein | affects cotreatment, increases oxidation, increases abundance | 1 |
| Vehicle Emissions | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
| Volatile Organic Compounds | affects cotreatment, increases oxidation | 1 |
Cellosaurus cell lines
3 cell lines: 2 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2ZY | Abcam HEK293T KXD1 KO | Transformed cell line | Female |
| CVCL_SV16 | HAP1 KXD1 (-) 1 | Cancer cell line | Male |
| CVCL_SV17 | HAP1 KXD1 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.